SIA
COGT icon

SkyView Investment Advisors’s Cogent Biosciences COGT Stock Holding History

SkyView Investment Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,133
Closed -$146K – 335
2025
Q3 		$146K Buy
10,133
+133
+1% +$1.58K 0.02% 269
2025
Q2 		$72K Hold
10,000
– – 0.01% 272
2025
Q1 		$60K Sell
10,000
-2,500
-20% -$19.6K 0.01% 269
2024
Q4 		$98K Hold
12,500
– – 0.02% 241
2024
Q3 		$135K Hold
12,500
– – 0.02% 225
2024
Q2 		$105K Buy
12,500
+2,500
+25% +$19K 0.02% 274
2024
Q1 		$67K Buy
+10,000
New +$61.8K 0.01% 262

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SkyView Investment Advisors's COGT Position: Q4 2025 in Review

SkyView Investment Advisors sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 10,133 shares — an estimated $146K sold.

SkyView Investment Advisors first reported a position in COGT in Q1 2024 and held it in 7 quarters. The position peaked at $146K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • SkyView Investment Advisors reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • SkyView Investment Advisors sold 10,133 Cogent Biosciences shares in Q4 2025, an estimated $146K.
  • SkyView Investment Advisors first reported a position in Cogent Biosciences in Q1 2024 and held it in 7 quarters.
  • SkyView Investment Advisors's Cogent Biosciences position peaked at $146K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on SkyView Investment Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.